4 years ago

Zedsen Raises $12 Million in Series B Funding to Expand Personalized Health Insights

  • Zedsen, a UK-based health tech company, has secured $12 million in Series B funding at a $110 million valuation

  • The funding round was led by Joseph R

  • Grano, former Chairman and CEO of UBS Financial Services Inc, along with other notable investors including Nasser Kazeminy, Tony Rice, Bonnie Mcalveen Hunter, and Jim Harpel

  • Zedsen aims to use the funds to expand its operations and business reach

  • The company specializes in non-invasive technology that uses data from the bloodstream to provide personalized health insights, fitness, and dietary recommendations.

      • ProblemHealthcare

      "It's hard to understand your health without invasive testing."

      Solution

      "Zedsen uses non-invasive sensors to gather data from your bloodstream, providing personalized insights about your health, fitness and diet."

      Covered on